DR. CUSHMAN PUBLISHES PEER REVIEWED RESEARCH ARTICLE ON KEY NUTRACEUTICALS

May 3, 2012

 

FOR IMMEDIATE RELEASE

A new peer reviewed article entitled “Primary Risks of Oral Contraceptives and HRT” discusses the benefits of two nutraceuticals- BRM4 and Plasmanex1, manufactured by Daiwa Pharmaceuticals, and researched by Dr. Gina Cushman in clinical practice.

(Newport Beach, CA) May 3, 2012- Gina Cushman, NMD, PhD, owner and founder of HealthBridge Medical Center and HealthBridge Management LLC in Newport Beach, CA  has just been published in the peer reviewed Natural Medicine Journal, the official journal of the American Association of Naturopathic Physicians. She discusses ways to offset the primary risks that women face when taking hormone replacement therapy (HRT) and oral contraceptives (OC) prescribed by their physicians, including the use of 2 natural food extracts–Plasmanex1 and BRM4–one showing anticoagulant effects and the other exhibiting certain anti-inflammatory and immunomodulatory effects.  Her discussion is based on the results of a clinical research study on the extracts, that was led by Dr. Cushman at her medical practice, and presented worldwide at three PharmCon peer-reviewed continuing medical education events on June 9th, 2011; July 7th, 2011; and August 10th, 2011.   

“I am pleased to see that our team at HealthBridge was able to research these nutraceuticals in a real world medical practice setting, identifying a new and important application for the products, and then share the results of our research with thousands of physicians and pharmacists worldwide, through continuing medical education seminars and now through publication in a reputable peer-reviewed journal, “ says Dr. Cushman.

Long-term use of OCs and HRT have been linked to increased risks of cardiovascular problems, and chronic immune disorders with an inflammatory component, including cancer.  The research study designed and led by Dr. Cushman investigated the clinical effects of the use of BRM4 (also referred to as BioBran, MGN3 or RBAC in some countries) and Plasmanex1 (NKCP) for the purpose of uncovering potential benefits of combined use, as well as areas that may prove fruitful for further research into ways to prevent serious side effects from OCs/HRT. The 6-week private practitioner research study included case study results that demonstrated the significant impact of these 2 extracts—Plasmanex1 and BRM4—on OC users and HRT users, with regard to offsetting thrombotic risk and improving inflammatory symptoms.

Reference: Cushman, G. Primary Risks of Oral Contraceptives and HRT. Nat Med Journal. May 1, 2012. http://naturalmedicinejournal.com/article_content.asp?edition=1&section=2&article=321

# # #
About HealthBridge Management LLC
HealthBridge Management LLC is a nationally recognized consulting firm specializing in medical marketing, sales and distribution for the pharmaceutical and nutraceutical industries.  HealthBridge delivers simple, affordable and doable medical sales, research and marketing solutions to meet the need, worldwide, for quality education, and access to effective pharmaceutical and nutraceutical products. For further information on our firm, partial client list and client comments, please visit www.HealthBridge.tv or call 949.612.9890.


Breast Cancer Linked to Popular Antidepressant Medication

May 7, 2011

Bloomberg reported on a research study revealing a link between female cancers and antidepressant use.

Scientists should more closely examine whether antidepressant drugs increase the risk of breast and ovarian cancer, according to a researcher affiliated with Harvard University whose review of 61 studies suggested a link.

The risk of cancer increased 11 percent on average for patients taking the medicines, according to a report that analyzed previous data and was published in yesterday’s issue of the peer-reviewed journal PLoS ONE. Read the full article by clicking here.

Preparing for a CME lecture (to air on PharmCon on June 9th, and categorized as live pharmacy hours for doctors) on  augmenting the side effects and risks associated with oral contraceptives and other synthetic hormones popular among women and teen-aged girls.  In addition to a significant increased risk in various cancers,  the synthetic hormones also decrease serotonin levels, further increasing the chance of a woman being prescribed anti-depressant medications which appear to further increase her risk of cancer!

A solution could be to take well researched immunomodulators like BRM4 if you take synthetic hormones, or to avoid these hormones if at all possible and turn to more natural options like Bioidentical Hormone Replacement Therapy.

In health and healing,

-Dr. G


Sickness Syndrome Depression-The Link Between Seasonal Allergies, Inflammation and Depression

April 12, 2011

A recent article in the New York Times discusses several large studies that link seasonal allergies to  depression and anxiety. The cause is an increase in inflammatory cytokines that lower serotonin levels.  This is a classic example of Sickness Syndrome Depression, a condition identified years ago and finally gaining media attention.  We often see cases of wrongly diagnosed anxiety and depression at our practice where patients are prescribed antidepressant medications instead of being treated for Sickness Syndrome Depression. To learn more about the syndrome click here. One treatment that is not yet mentioned on the site but that we have recently been using successfully in practice to treat Sickness Syndrome Depression and other psychiatric illnesses with an inflammatory component is BRM4 by Daiwa Health Development- an immunomodulator that alters levels of inflammatory cytokines throughout the body. The effective dosage is 4 capsules three times per day for 4 weeks, and then 4 capsules per day thereafter.

In health and healing,

-Dr. G


Follow

Get every new post delivered to your Inbox.

Join 357 other followers

%d bloggers like this: